22 Apr 24
tranScrip Ltd, a leading specialist pharmaceutical consultancy that provides strategic expertise, therapeutic experience, and operational excellence across the entire product lifecycle, is pleased to announce the appointment of Dr Rienk Pypstra as Chief Medical Officer.
“This will be a pivotal year for tranScrip as we strive to enable our clients to maximise the value of their innovative products for the benefit of patients worldwide. I am very pleased to have Rienk join our Leadership Team as we accelerate our efforts to build on our past success, identify new revenue opportunities, and use the experience of our world-class team members to deepen our relationships with clients.” said Mark Corbett, Chief Executive Officer. “Rienk brings a wealth of experience in clinical development and his appointment speaks to the unique calibre of clinical expertise that tranScrip offers our clients. I am confident that he will excel in his new role and further enhance the quality and efficiency of our client services.”
Dr Pypstra is an established, medically qualified, drug development expert, having led numerous development programmes both in biotech and big pharma, through early and late-stage clinical development, to regulatory approvals, market access and successful commercialisation. His experience also spans the business side of pharma, with extensive experience in licensing and acquisition deals, including leading clinical due diligence for a number of assets. Over the past 7 years, Rienk has been VP Clinical Development for the Infectious Diseases (ID) Portfolio at Pfizer, where he started by integrating the AstraZeneca antibiotics portfolio, and subsequently drove various acquisitions and integrations in the ID space.
tranScrip’s Executive Leadership team is completed by Mark Corbett,Chief Executive Officer,Gareth Dyson, Chief Financial Officer, Linda Summerton, Chief Scientific Officer, Karen Nugent, Chief Operating Officer, and Stacey Godfrey, Chief People Officer. For information on the full leadership team, please visit https://www.transcrip-group.com/about-us/our-leaders/
Our experienced physicians and scientists, together with our regulatory, clinical and commercial experts can support you to maximise the value of your products. Whatever your project requires, we have the expertise to meet your needs.
